GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: APO-66 | CP20 | Ferriprox®
                                 
                                                         
                            
                            
                            
                                 
                                
                                deferiprone is an approved drug (EMA (1999), FDA (2011)) 
                                                        
                                                    
                                Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Deferiprone is an iron-chelating drug.
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                      
                                     
                                   
                                   
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| No information available. | 
Summary of Clinical Use ![]()  | 
                                                        
| Patients with thalassaemia often require repeated blood transfusions to maintain red blood cell levels, but this type of treatment can lead to potentially fatal iron overload. | 
Mechanism Of Action and Pharmacodynamic Effects ![]()  | 
                                                        
| Deferiprone chelates the excess iron in thalassemia patients [1], and effects its removal and excretion. | 
External links ![]()  | 
                                                            
| 
                                                                    For extended ADME data see the following: Electronic Medicines Compendium (eMC) Drugs.com European Medicines Agency (EMA)  |